Antoine Avignon
CHU Montpellier
Metabolic Diseases Department
Lapeyronie Hospital
Montpellier
France
Name/email consistency: high
- Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. Avignon, A., Sultan, A., Piot, C., Mariano-Goulart, D., Thuan Dit Dieudonné, J.F., Cristol, J.P., Dupuy, A.M. Diabetes. Care (2007)
- PKC-B inhibition: a new therapeutic approach for diabetic complications?. Avignon, A., Sultan, A. Diabetes Metab. (2006)
- Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Avignon, A., Sultan, A., Piot, C., Elaerts, S., Cristol, J.P., Dupuy, A.M. Diabetes. Care (2005)
- Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin. Avignon, A., Lapinski, H., Rabasa-Lhoret, R., Caubel, C., Boniface, H., Monnier, L. Diabetes. Obes. Metab (2000)









